Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases

참고문헌 (99)

1. Despres, J. P., "Abdominal obesity and metabolic syndrome", Nature, 444, pp.881~887 (2006)
2. Zhou, Q. Q., "Advancing targeted protein degradation for metabolic diseases therapy", Pharm. Res, 188, pp.106627~ (2023)
3. Amm, I., "Protein quality control and elimination of protein waste : the role of the ubiquitin-proteasome system", BBA Mol. Cell Res, 1843, pp.182~196 (2014)
4. Morgan, J. J, "The ubiquitin proteasome system in genome stability and cancer", Cancers, 13, pp.2235~ (2021)
5. Balaji, V., "Ubiquitylation pathways in insulin signaling and organismal homeostasis", Bioessays, 40, pp.e1700223~ (2018)
6. Shah, S. S., "Adaptors as the regulators of HECT ubiquitin ligases(vol 89, pg 613, 2020)", Cell Death Differ, 28, pp.3196~3196 (2021)
7. Zheng, N, "Ubiquitin ligases : structure, function, and regulation", Annu Rev. Biochem, 86, pp.129~157 (2017)
8. Kamadurai, H. B., "Insights into ubiauitin transfer cascades from a structure of a UbcH5B similar to ubiauitin-HECTNEDD4L complex", Mol. Cell, 36, pp.1095~1102 (2009)
9. Fajner, V., "Targeting HECT-type E3 ligases-insights from catalysis, regulation and inhibitors", FEBS Lett, 591, pp.2636~2647 (2017)
10. Sanchez-Tena, S., "Functional and pathological relevance of HERC family proteins : a decade later", Cell Mol. Life Sci, 73, pp.1955~1968 (2016)
11. Weber, J., "HECT E3 ligases : a tale with multiple facets", Front. Physiol, 10, pp.370~ (2019)
12. Leon, S., "Ubiquitin ligase adaptors : regulators of ubiquitylation and endocytosis of plasma membrane proteins", Exp. Cell Res, 315, pp.1574~1583 (2009)
13. Scheffner, M., "Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade", Nature, 373, pp.81~83 (1995)
14. Scheffner, M., "Mammalian HECT ubiquitin-protein ligases : biological and pathophysiological aspects", Biochim. Biophys. Acta, 1843, pp.61~74 (2014)
15. Wenzel, D. M., "UBCH7 reactivity profile reveals parkin and HHARI to be RING", HECT hybrids, 2011, pp.474, 105~136
16. Walden, H., "RBR ligase-mediated ubiquitin transfer : a tale with many twists and turns", Nat. Struct. Mol. Biol, 25, pp.440~445 (2018)
17. Smit, J. J., "RBR E3-ligases at work", EMBO Rep, 15, pp.142~154 (2014)
18. Dove, K. K., "RING-between-RING E3 ligases : emerging themes amid the variations", J. Mol. Biol, 429, pp.3363~3375 (2017)
19. Wang, P., "RBR E3 ubiquitin ligases in tumorigenesis", Semin. Cancer Biol, 67, pp.131~144 (2020)
20. Deshaies, R. J., "RING domain E3 ubiquitin ligases", Annu. Rev. Biochem, 78, pp.399~434 (2009)
21. Petroski, M. D, "Function and regulation of Cullin-RING ubiquitin ligases", Nat. Rev. Mol. Cell Biol, 6, pp.9~20 (2005)
22. Sarikas, A., "The cullin protein family", Genome Biol, 12, pp.220~ (2011)
23. Sun, Y., "Functional characterization of SAG", RBX2, RNF7, an antioxidant protein and an E3 ubiquitin ligase, pp.Protein Cell, 2013[DOI]
24. Kamura, T., "VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases", Gene Dev, 18, pp.3055~3065 (2004)
25. Xu, L., "BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3", Nature, 425, pp.316~321 (2003)
26. Jin, J. P., "A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1", Mol. Cell, 23, pp.709~721 (2006)
27. Jackson, S., "CRL4s : the CUL4-RING E3 ubiquitin ligases", Trends Biochem. Sci, 34, pp.562~570 (2009)
28. Marin, I., "Diversification of the cullin family", BMC Evol. Biol, 9, pp.267~ (2009)
29. Dias, D. C., "CUL7: a DOC domain-containing cullin selectively binds Skp1 center dot Fbx29 to form an SCF-like complex", Proc. Natl Acad. Sci. USA, 99, pp.16601~16606 (2002)
30. Deshaies, R. J., "SCF and cullin", RING H2-based ubiquitin ligases, 1999, pp.15, 435~467
31. Sun, Y., "SAG", ROC, Hrt, a zinc RING finger gene family: Molecular cloning, biochemical properties, and biological functions, pp.Antioxid. Redox Signal, 2001[DOI]
32. Wu, K., "The SCFHOS", beta-TRCP-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation, 2000, pp.20, 1382~1393
33. Goldenberg, S. J., "Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases", Cell, 119, pp.517~528 (2004)
34. Mahrour, N., "Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to elongin BC-based ubiquitin ligases", J. Biol. Chem, 283, pp.8005~8013 (2008)
35. Wang, P., "CRL3s : the BTB-CUL3-RING E3 ubiquitin ligases", Adv. Exp. Med. Biol, 1217, pp.211~223 (2020)
36. Tong, K. I., "Different electrostatic Potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response", Mol. Cell Biol, 27, pp.7511~7521 (2007)
37. Errington, W. J., "Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase", Structure, 20, pp.1141~1153 (2012)
38. Beaulieu, A. M., "The BTB-ZF family of transcription factors : key regulators of lineage commitment and effector function development in the immune system", J. Immunol, 187, pp.2841~2847 (2011)
39. Nguyen, H. C., "Cullin-RING E3 ubiquitin ligases : bridges to destruction", Subcell. Biochem, 83, pp.323~347 (2017)
40. Fischer, E. S., "The molecular basis of CRL4(DDB2", CSA)ubiquitin ligase architecture, targeting, and activation, 2011, pp.147, 1024~1039
41. Hatakeyama, S., "TRIM family proteins : roles in autophagy, immunity, and carcinogenesis", Trends Biochem. Sci, 42, pp.297~311 (2017)
42. Lu, K., "TRIM proteins in hepatocellular carcinoma", J. Biomed. Sci, 29, pp.69~ (2022)
43. Zaman, M. M. U., "Trim27-deficient mice are susceptible to streptozotocin-induced diabetes", FEBS Open Bio, 4, pp.60~64 (2014)
44. Cohen, S., "Trim32 reduces PI3K-Akt-FoxO signaling in muscle atrophy by promoting plakoglobin-PI3K dissociation", J. Cell Biol, 204, pp.747~758 (2014)
45. Wu, H. K., "Glucose-sensitive myokine", cardiokine MG53 regulates systemic insulin response and metabolic homeostasis, 2019, pp.139, 901~914
46. Song, R. S., "Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders", Nature, 494, pp.375~379 (2013)
47. Liu, F. H., "Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor alpha", Circulation, 131, pp.795~ (2015)
48. Bodine, S. C., "Identification of ubiquitin ligases required for skeletal muscle atrophy", Science, 294, pp.1704~1708 (2001)
49. Lecker, S. H., "Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression", Faseb J, 18, pp.39~51 (2004)
50. 박준섭, "An MG53-IRS1-interaction disruptor ameliorates insulin resistance", Experimental and Molecular Medicine, 50, pp.1~12 (2018), 생화학분자생물학회
51. Adams, V., "Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility", J. Cachexia Sarcopenia Muscle, 13, pp.1565~1581 (2022)
52. Das, A., "The structure and ubiquitin binding properties of TRAF RING heterodimers", J. Mol. Biol, 433, pp.166844~ (2021)
53. Park, H. H., "Structure of TRAF family : current understanding of receptor recognition", Front. Immunol, 9, pp.1999~ (2018)
54. Inoue, J., "Tumor necrosis factor receptor-associated factor(TRAF)family : adapter proteins that mediate cytokine signaling", Exp. Cell Res, 254, pp.14~24 (2000)
55. Bradley, J. R., "Tumor necrosis factor receptor-associated factors (TRAFs)", Oncogene, 20, pp.6482~6491 (2001)
56. Arch, R. H., "Tumor necrosis factor receptorassociated factors(TRAFs)-a family of adapter proteins that regulates life and death", Genes Dev, 12, pp.2821~2830 (1998)
57. Yang, W. L., "The E3 ligase TRAF6 regulates Akt ubiquitination and activation", Science, 325, pp.1134~1138 (2009)
58. Chatzigeorgiou, A., "Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance", Proc. Natl Acad. Sci. USA, 111, pp.4644~4644 (2014)
59. Chen, Z., "Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses", Diabetes, 61, pp.566~573 (2012)
60. Bauer, J., "Overview of the membrane-associated RING-CH(MARCH)E3 ligase family", N. Biotechnol, 38, pp.7~15 (2017)
61. Ohmura-Hoshino, M., "A novel family of membrane-bound E3 ubiquitin ligases", J. Biochem, 140, pp.147~154 (2006)
62. Lin, H., "The membrane-associated MARCH E3 ligase family : emerging roles in immune regulation", Front. Immunol, 10, pp.1751~ (2019)
63. Sharpe, L. J., "Cholesterol increases protein levels of the E3 ligase MARCH6and thereby stimulates protein degradation", J. Biol. Chem, 294, pp.2436~2448 (2019)
64. Zelcer, N., "The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme a reductase and the cholesterol synthesis pathway", Mol. Cell Biol, 34, pp.1262~1270 (2014)
65. Foresti, O., "Sterol homeostasis requires regulated degradation of squalene monooxygenase by the ubiquitin ligase Doa10", Teb4, 2013, pp.2, e00953~
66. Scott, N. A., "The cholesterol synthesis enzyme lanosterol 14 alphademethylase is post-translationally regulated by the E3 ubiquitin ligase MARCH6", Biochem. J, 477, pp.541~555 (2020)
67. Nguyen, K. T., "N-terminal acetylation and the N-end rule pathway control degradation of the lipid droplet protein PLIN2", J. Biol. Chem, 294, pp.379~388 (2019)
68. Schultz, M. L., "Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERAD", Nat. Commun, 9, pp.3671~ (2018)
69. Wang, L., "Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II", Hepatology, 48, pp.1558~1569 (2008)
70. Nagarajan, A., "MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels", Nat. Commun, 7, pp.12639~ (2016)
71. Bhagwandin, C., "The E3 ubiquitin ligase MARCH1 regulates glucosetolerance and lipid storage in a sex-specific manner", Plos One, 13, pp.e0204898~ (2018)
72. Boyden, L. M., "Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities", Nature, 482, pp.98~ (2012)
73. Dhanoa, B. S., "Update on the Kelch-like (KLHL) gene family", Hum. Genomics, 7, pp.13~ (2013)
74. McCormick, J. A., "Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3", J. Clin. Invest, 124, pp.4723~4736 (2014)
75. Pathare, G., "A molecular update on pseudohypoaldosteronism type II", Am. J. Physiol. Ren, 305, pp.F1513~F1520 (2013)
76. Takahashi, D., "WNK4 is an adipogenic factor and its deletion reduces dietinduced obesity in mice", Ebiomedicine, 18, pp.118~127 (2017)
77. Guo, Q., "Decreased KLHL3 expression is involved in the activation of WNK-OSR1", SPAK-NCC cascade in type 1 diabetic mice, 2021, pp.473, 185~196
78. Jang Ju-hong, "KLHL3 deficiency in mice ameliorates obesity, insulin resistance, and nonalcoholic fatty liver disease by regulating energy expenditure", Experimental and Molecular Medicine, 54, pp.1~12 (2022), 생화학분자생물학회[DOI]
79. Yamamoto, M., "The Keap1-Nrf2 system : a thiolbased sensor-effector apparatus for maintaining redox homeostasis", Physiol. Rev, 98, pp.1169~1203 (2018)
80. de la Vega, M. R., "NRF2 and the hallmarks of cancer", Cancer Cell, 34, pp.21~43 (2018)
81. Zhang, Y. K. J., "Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine-and cholinedeficient diet", Toxicol. Appl. Pharm, 245, pp.326~334 (2010)
82. Yates, M. S., "Genetic versus chemoprotective activation of Nrf2 signaling : overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice", Carcinogenesis, 30, pp.1024~1031 (2009)
83. Saito, T., "p62", Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming, 2016, pp.7, 12030~
84. Teng, X. C., "KCTD : A new gene family involved in neurodevelopmental and neuropsychiatric disorders", CNS Neurosci. Ther, 25, pp.887~902 (2019)
85. Liu, Z. P., "The KCTD family of proteins : structure, function, disease relevance", Cell Biosci, 3, pp.45~ (2013)
86. Perez-Torrado, R., "Born to bind : the BTB proteinprotein interaction domain", Bioessays, 28, pp.1194~1202 (2006)
87. Furukawa, M., "Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases", Nat. Cell Biol, 5, pp.1001~1007 (2003)
88. Pinkas, D. M., "Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases", Biochem. J, 474, pp.3747~3761 (2017)
89. Marneros, A. G., "Mutations in KCTD1 cause scalp-ear-nipple syndrome", Am. J. Hum. Genet, 92, pp.621~626 (2013)
90. Yoganathan, P., "Nutritional regulation of genome-wide association obesity genes in a tissue-dependent manner", Nutr. Metab, 9, pp.65~ (2012)
91. Junyent, M., "Novel variants at KCTD10, MVK, and MMAB genes interact with dietary carbohydrates to modulate HDL-cholesterol concentrations in the Genetics of Lipid Lowering Drugs and Diet Network Study", Am. J. Clin. Nutr, 90, pp.686~694 (2009)
92. Williams, M. J., "Obesity-linked homologues TfAP-2 and Twz establish meal frequency in Drosophila melanogaster", Plos Genet, 10, pp.e1004499~ (2014)
93. Zarelli, V. E., "Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2", Proc. Natl. Acad. Sci. USA, 110, pp.2870~2875 (2013)
94. Smaldone, G., "The essential player in adipogenesis GRP78 is a novel KCTD15interactor", Int J. Biol. Macromol, 115, pp.469~475 (2018)
95. Inaba, H., "Ndel1 suppresses ciliogenesis in proliferating cells by regulating the trichoplein-Aurora A pathway", J. Cell Biol, 212, pp.409~423 (2016)
96. Kasahara, K., "Ubiquitin-proteasome system controls ciliogenesis at the initial step of axoneme extension", Nat. Commun, 5, pp.5081~ (2014)
97. Kim, K., "Degradation of PHLPP2 by KCTD17, via a glucagon-dependent pathway, promotes hepatic steatosis", Gastroenterology, 153, pp.1568~ (2017)
98. Oh, A. R., "Hepatocyte Kctd17 inhibition ameliorates glucose intolerance and hepatic steatosis caused by obesity-induced Chrebp stabilization", Gastroenterology, 164, pp.439~453 (2023)
99. Shin, M. C., "Kctd17-mediated Chop degradation promotes adipogenic differentiation", Biochem. Bioph. Res. Co, 653, pp.126~132 (2023)

관련 논문AI추천